These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12138900)

  • 1. In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.
    Ishii E; Eguchi M; Eguchi-Ishimae M; Yoshida N; Oda M; Zaitsu M; Fujita I; Miyazaki S; Hamasaki Y; Mizutani S
    Int J Hematol; 2002 Jul; 76(1):74-9. PubMed ID: 12138900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias.
    Cimino G; Rapanotti MC; Biondi A; Elia L; Lo Coco F; Price C; Rossi V; Rivolta A; Canaani E; Croce CM; Mandelli F; Greaves M
    Cancer Res; 1997 Jul; 57(14):2879-83. PubMed ID: 9230194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
    Lovett BD; Strumberg D; Blair IA; Pang S; Burden DA; Megonigal MD; Rappaport EF; Rebbeck TR; Osheroff N; Pommier YG; Felix CA
    Biochemistry; 2001 Feb; 40(5):1159-70. PubMed ID: 11170441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
    Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
    Strick R; Strissel PL; Borgers S; Smith SL; Rowley JD
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4790-5. PubMed ID: 10758153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
    Aplan PD; Chervinsky DS; Stanulla M; Burhans WC
    Blood; 1996 Apr; 87(7):2649-58. PubMed ID: 8639880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
    Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
    Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.
    Stanulla M; Wang J; Chervinsky DS; Thandla S; Aplan PD
    Mol Cell Biol; 1997 Jul; 17(7):4070-9. PubMed ID: 9199342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: a prospective study.
    Ng A; Taylor GM; Wynn RF; Eden OB
    Leukemia; 2005 Feb; 19(2):253-9. PubMed ID: 15592432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
    Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
    Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the MLL breakpoint cluster region (BCR).
    Echlin-Bell DR; Smith LL; Li L; Strissel PL; Strick R; Gupta V; Banerjee J; Larson R; Relling MV; Raimondi SC; Hayashi Y; Taki T; Zeleznik-Le N; Rowley JD
    Hum Genet; 2003 Jul; 113(1):80-91. PubMed ID: 12665971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.
    Megonigal MD; Cheung NK; Rappaport EF; Nowell PC; Wilson RB; Jones DH; Addya K; Leonard DG; Kushner BH; Williams TM; Lange BJ; Felix CA
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2814-9. PubMed ID: 10706619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
    Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
    Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion.
    Alexander FE; Patheal SL; Biondi A; Brandalise S; Cabrera ME; Chan LC; Chen Z; Cimino G; Cordoba JC; Gu LJ; Hussein H; Ishii E; Kamel AM; Labra S; Magalhães IQ; Mizutani S; Petridou E; de Oliveira MP; Yuen P; Wiemels JL; Greaves MF
    Cancer Res; 2001 Mar; 61(6):2542-6. PubMed ID: 11289128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide induces chimeric Mll gene fusions.
    Blanco JG; Edick MJ; Relling MV
    FASEB J; 2004 Jan; 18(1):173-5. PubMed ID: 14630694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion.
    Libura J; Slater DJ; Felix CA; Richardson C
    Blood; 2005 Mar; 105(5):2124-31. PubMed ID: 15528316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.